Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1996-9-17
|
pubmed:abstractText |
Total lymphoid irradiation (640 cGy) was given to 19 heart and 1 heart-lung recipients on maintenance triple therapy at a mean of 4.9 +/- 4 months after transplantation (range 46 to 519 days). Mean number of treated rejection episodes before, during, and after total lymphoid irradiation was 6.4 +/- 1.7, 0.8 +/- 1.2, and 1.2 +/- 1.3 episodes per patient, respectively. During total lymphoid irradiation, 37% had at least one episode of rejection requiring treatment; after total lymphoid irradiation, 42% had no further rejection episodes, 21% had one further episode, and 37% had 2 or more episodes. Metastatic squamous cell carcinoma in one patient and coronary artery disease in three of five patients studied to date is of concern and requires longer follow-up.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1053-2498
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
231-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8777203-Adult,
pubmed-meshheading:8777203-Drug Therapy, Combination,
pubmed-meshheading:8777203-Female,
pubmed-meshheading:8777203-Follow-Up Studies,
pubmed-meshheading:8777203-Graft Rejection,
pubmed-meshheading:8777203-Heart Transplantation,
pubmed-meshheading:8777203-Heart-Lung Transplantation,
pubmed-meshheading:8777203-Humans,
pubmed-meshheading:8777203-Immunity, Cellular,
pubmed-meshheading:8777203-Immunosuppressive Agents,
pubmed-meshheading:8777203-Lymphatic Irradiation,
pubmed-meshheading:8777203-Lymphocyte Depletion,
pubmed-meshheading:8777203-Male,
pubmed-meshheading:8777203-Middle Aged,
pubmed-meshheading:8777203-Radiotherapy Dosage,
pubmed-meshheading:8777203-Survival Analysis
|
pubmed:year |
1996
|
pubmed:articleTitle |
Clinical heart transplantation. Total lymphoid irradiation for resistant rejection after heart transplantation: only moderate success medium-term.
|
pubmed:affiliation |
Heart and Lung Transplant Unit, Victor Chang Research Institute, Darlinghurst, Sydney, Australia.
|
pubmed:publicationType |
Journal Article
|